COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00200720
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : December 6, 2012
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Kaiser Permanente

Brief Summary:
This study will examine the effects of a low carbohydrate diet versus a high carbohydrate diet on weight loss.

Condition or disease Intervention/treatment Phase
Obesity Hypertension Behavioral: Atkins diet (low carbohydrate diet) Behavioral: DASH diet (high carbohydrate diet) Phase 2

Detailed Description:

The number of overweight and obese Americans has increased significantly in recent years. There are now many different diet plans being promoted by doctors and the media. The Atkins diet, a low carbohydrate nutritional plan, is especially popular; its advocates claim that following the diet will result in long-term weight loss with no negative effects. Another diet, called the Dietary Approaches to Stop Hypertension (DASH) diet, is a high carbohydrate diet designed to help treat and prevent high blood pressure. However, more thorough investigation of these claims is needed. This study will compare the short- and long-term effects of the Atkins diet to the (DASH) diet. This trial will enroll overweight and obese participants.

This study will last 30 months and will comprise two phases. Participants will be randomly assigned to either the Atkins or DASH diet for 30 months. During Phase 1, all participants will undergo 6 months of weekly group therapy to encourage weight loss. Phase 2 is a weight loss maintenance phase. During Phase 2, participants will have monthly meetings with a therapist for weight loss support. Study visits will occur at study entry and at Months 3 and 30. At each study visit, weight measurements, blood and urine collection, and x-rays will occur to determine participants' weight loss, cardiovascular health, kidney function, and bone density.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 260 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Metabolic Consequences of High and Low Carbohydrate Diets
Study Start Date : April 2005
Actual Primary Completion Date : March 2009
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Atkins Diet
Participants randomized to this arm will consume a low carbohydrate diet as described by Dr. Robert Atkins in his book: Dr. Atkins' New Diet Revolution New York: Avon Books, 2002.
Behavioral: Atkins diet (low carbohydrate diet)
Active Comparator: DASH Diet
Participants randomized to this arm will consume the Dietary Approaches to Stop Hypertension (DASH) diet as described here:
Behavioral: DASH diet (high carbohydrate diet)

Primary Outcome Measures :
  1. Weight loss [ Time Frame: monthly ]
    Excess weight loss (greater than 5 pounds a week)would trigger patient assessment.

Secondary Outcome Measures :
  1. Risk of cardiovascular disease [ Time Frame: Every six months ]
    Elevated lipids or rising blood pressure during six month safety assessments would trigger additional participant evaluation

  2. bone health [ Time Frame: end of study ]
  3. kidney function [ Time Frame: every six months ]
  4. neuroendocrine mechanisms of hunger and satiety [ Time Frame: end of study ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Body mass index (BMI) of 27 to 50
  • Fasting glucose less than 126 mg/dl
  • Total fasting cholesterol less than 260 mg/dl
  • Total fasting triglycerides less than 400 mg/dl
  • Permission of primary care provider to participate in the study
  • Normal liver and kidney function
  • Willing to modify diet and other health behaviors
  • Willing to use an acceptable method of contraception for the duration of the study

Exclusion Criteria:

  • Any medical condition that may make weight loss medically inadvisable
  • Weigh more than 400 lbs
  • History of kidney failure
  • Current use of more than 3 blood pressure medications
  • Change in blood pressure medications within 3 months prior to study entry
  • Diagnosis of cardiovascular disease within 6 months prior to study entry
  • Cancer diagnosis within 2 years of study entry. Participants with basal cell skin cancer are not excluded.
  • History of psychiatric hospitalization within 2 years prior to study entry
  • Consumption of more than three alcoholic drinks a day
  • Type I or II diabetes
  • Current use of hypolipidemics, antipsychotics, hypoglycemics, glucocorticoids, or thyroid medication
  • Plan to move during study
  • Current participation in another clinical trial
  • Pregnancy or breastfeeding

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00200720

Layout table for location information
United States, Oregon
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227
Sponsors and Collaborators
Kaiser Permanente
National Center for Complementary and Integrative Health (NCCIH)
Layout table for investigator information
Principal Investigator: Njeri Karanja, PhD Kaiser Permanente
Layout table for additonal information
Responsible Party: Kaiser Permanente Identifier: NCT00200720    
Other Study ID Numbers: R21AT000525-01 ( U.S. NIH Grant/Contract )
R21AT000525-01 ( U.S. NIH Grant/Contract )
1R01AT001930 ( U.S. NIH Grant/Contract )
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: December 6, 2012
Last Verified: February 2008
Keywords provided by Kaiser Permanente:
Weight Loss
Additional relevant MeSH terms:
Layout table for MeSH terms
Weight Loss
Vascular Diseases
Cardiovascular Diseases
Body Weight Changes
Body Weight
Signs and Symptoms